Niraparib/abiraterone acetate
Niraparib/Abiraterone Acetate is a combination of two drugs, Niraparib and Abiraterone Acetate, used in the treatment of certain types of cancer.
Niraparib[edit]
Niraparib is a poly ADP-ribose polymerase (PARP) inhibitor used primarily in the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. It works by inhibiting the enzyme PARP, which is involved in DNA repair. By inhibiting this enzyme, DNA damage in cancer cells accumulates, leading to cell death.
Abiraterone Acetate[edit]
Abiraterone Acetate is a CYP17 inhibitor used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting the production of androgens (male hormones) which are known to fuel the growth of prostate cancer.
Combination Therapy[edit]
The combination of Niraparib and Abiraterone Acetate is currently being studied in clinical trials for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The rationale behind this combination is to exploit the synergistic effects of a PARP inhibitor and a CYP17 inhibitor in treating prostate cancer.
Side Effects[edit]
Like all medications, Niraparib and Abiraterone Acetate can cause side effects. Common side effects of Niraparib include nausea, fatigue, constipation, and thrombocytopenia. Common side effects of Abiraterone Acetate include fatigue, joint pain, hypertension, and hypokalemia.
See Also[edit]
References[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
